A new drug that quickly undoes the effects of anesthesia could be approved and available by the end of this year. Suggamadex, which would be marketed under the name Bridion, would be administered after surgery to rapidly reverse the mild to serious muscle-relaxing impact of the most widely-used anesthetic products.
An FDA advisory panel has already unanimously approved suggamadex, and the agency typically follows panel recommendations. However, the decision has been postponed by a few months to allow time for additional side-effect research. In trials so far, less than one percent of patients had a reaction, which most commonly manifested as a minor change in bone strength.
Find a Doctor
Find a NewBeauty "Top Beauty Doctor" Near you